|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net of allowance for doubtful accounts of $12,772 and $11,856 in 2026 and 2025, respectively | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Operating lease right of use assets | ||||||||||||||||||||
| Financing lease right of use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Current maturities of long-term debt, net of deferred financing costs of $234 and $396 in 2026 and 2025, respectively | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Current financing lease liabilities | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Deferred income | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of deferred financing costs of $24,337 and $29,517 in 2026 and 2025, respectively | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Financing lease liabilities | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Series AA preferred stock, par value $0.001, $63.80 cumulative dividends, 5,720 shares authorized; 5,720 shares issued and outstanding at 2026 and 2025 | ||||||||||||||||||||
| Total series AA preferred stock, par value $0.001, $63.80 cumulative dividends, 5,720 shares authorized; 5,720 shares issued and outstanding at 2026 and 2025 | ||||||||||||||||||||
| Common stock, value | ||||||||||||||||||||
| Class A CMN Stock | ||||||||||||||||||||
| Class B CMN Stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Cost of shares held in treasury, 2,384,228 and 2,338,692 shares at 2026 and 2025, respectively | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...